Effect Of Propionyl-L-carnitine On Exercise Performance In Peripheral Arterial Disease
| Effect | None |
| Values | Although the overall effect of propionyl l-carnitine on walking was not significant, four of the subjects did see considerable improvements, suggesting there could be "responders" and "non-responders" to the treatment. |
| Trial Design | Randomized trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 7 |
| Sex | n/a |
| Age Range | 45-64, 65+ |
In this crossover study, individuals with intermittent claudication and peripheral artery disease underwent three different four-week conditions: a baseline condition followed by a condition where they supplemented 500 mg propionyl l-carnitine twice daily and a condition where they received a placebo.
